Novavax Inc (NVAX)

[chrismiss_everyday]

Trial also achieves statistical significance in key secondary endpoints

Novavax to submit a U.S. BLA under FDA’s accelerated approval pathway

Company to host investor conference call today at 8:30 a.m. EDT

Webcast Conference Call

Novavax will host a webcast/conference call today at 8:30 a.m. ET. The webcast can be accessed via a link on the home page of the Novavax website (novavax.com) or through the “Investor Info”/“Events” tab on the Novavax website. Listeners who wish to ask questions or don’t have internet access can dial-in to the conference call at [phone] (domestic) or [phone] (international) and use passcode 4498251.

A replay of the webcast will be available on the Novavax website until June 24, 2020 and a replay of the conference call only will be available starting at 11:30 a.m. ET on March 24, 2020 until 11:30 a.m. ET on March 31, 2020. To access the conference call replay, dial [phone] (domestic) or [phone] (international) and use passcode 4498251.